Literature DB >> 5032153

Hepatotoxicity in rifampin-isoniazid treated patients related to their rate of isoniazid inactivation.

J Smith, W F Tyrell, A Gow, G W Allan, A W Lees.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1972        PMID: 5032153     DOI: 10.1378/chest.61.6_supplement.587

Source DB:  PubMed          Journal:  Chest        ISSN: 0012-3692            Impact factor:   9.410


× No keyword cloud information.
  6 in total

1.  Eidotorial: Antituberculous drugs and the liver.

Authors: 
Journal:  Br Med J       Date:  1975-06-07

2.  New drug regimens in the treatment of tuberculosis.

Authors:  E Wolinsky
Journal:  Bull N Y Acad Med       Date:  1975-10

3.  Determination of acetylator status in uraemia.

Authors:  A Fine; D J Sumner
Journal:  Br J Clin Pharmacol       Date:  1975-10       Impact factor: 4.335

4.  Fulminant hepatitis during treatment with rifampicin, pyrazinamid and ethambutol.

Authors:  W M van Aalderen; H Knoester; K Knol
Journal:  Eur J Pediatr       Date:  1987-05       Impact factor: 3.183

Review 5.  Clinical pharmacokinetics of isoniazid.

Authors:  W W Weber; D W Hein
Journal:  Clin Pharmacokinet       Date:  1979 Nov-Dec       Impact factor: 6.447

6.  Genetic Variations Associated with Anti-Tuberculosis Drug-Induced Liver Injury.

Authors:  Yifan Bao; Xiaochao Ma; Theodore P Rasmussen; Xiao-Bo Zhong
Journal:  Curr Pharmacol Rep       Date:  2018-03-15
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.